SINT Key Statistics, Chart & Performance
The current stock price of SINT is 3.78 USD. In the past month the price decreased by -6.44%. In the past year, price increased by 11.5%.
SINT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About SINT
Company Profile
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Company Info
SINTX TECHNOLOGIES INC
1885 West 2100 Street
Salt Lake City UTAH 84119 US
CEO: B. Sonny Bal
Employees: 20
Phone: 18018393516
SINTX TECHNOLOGIES INC / SINT FAQ
Can you describe the business of SINTX TECHNOLOGIES INC?
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
What is the stock price of SINTX TECHNOLOGIES INC today?
The current stock price of SINT is 3.78 USD. The price decreased by -1.31% in the last trading session.
Does SINT stock pay dividends?
SINT does not pay a dividend.
What is the ChartMill rating of SINTX TECHNOLOGIES INC stock?
SINT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of SINT stock?
SINTX TECHNOLOGIES INC (SINT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of SINT stock?
SINTX TECHNOLOGIES INC (SINT) has a market capitalization of 14.55M USD. This makes SINT a Nano Cap stock.
SINT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SINT. When comparing the yearly performance of all stocks, SINT turns out to be only a medium performer in the overall market: it outperformed 40.23% of all stocks.
SINT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SINT. While SINT seems to be doing ok healthwise, there are quite some concerns on its profitability.
SINT Financial Highlights
Over the last trailing twelve months SINT reported a non-GAAP Earnings per Share(EPS) of -6.8. The EPS increased by 92.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.75% | ||
| ROE | -407.15% | ||
| Debt/Equity | 0 |
SINT Forecast & Estimates
7 analysts have analysed SINT and the average price target is 16.32 USD. This implies a price increase of 331.75% is expected in the next year compared to the current price of 3.78.
For the next year, analysts expect an EPS growth of 62.03% and a revenue growth -67.16% for SINT